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Summary 
We have recently shown that recognition of the mouse mammary tumor virus 9-associated 
superantigen (vSAG-9) by routine VB17 ~ T  cells is strongly influenced by the major histo- 
compatibility complex (MHC) class II haplotype of the presenting cells, resulting in a form 
of MHC-restricted recognition. This finding was unexpected, because T cell recognition of another 
well-characterized  retroviral superantigen, minor lymphocyte-stimulating  antigen 1 (Mls-1), had 
been shown to be independent of the MHC haplotype of the presenting cell. To determine whether 
recognition of vSAG-9 and Mls-1 is fundamentally different, we undertook an extensive analysis 
of MHC haplotype influences on vSAG-9 and Mls-1 recognition by panels of T cell hybridomas. 
Our results show that, although most hybridomas recognized Mls-1 regardless of the MHC 
haplotype of the presenting cells, as previously described by others, some hybridomas exhibited 
unique patterns of MHC fine specificity. Thus, T cell recognition of vSAG-9 and Mls-1 is not 
fundamentally different, but the apparent differences can be explained in terms of frequency. 
The MHC fine specificity of individual Mls-l-reactive hybridomas was influenced by both VB 
and non-V~/T cell receptor (TCR) elements. First, the influence of the VB element was apparent 
from the observation that VB8.2 + hybridomas were significantly more MHC specific in their 
recognition of Mls-1 than V~8.1 hybridomas. Second, a role for the TCR ol chain was implicated 
from the distinct patterns of fine specificity of Mls-1 reactivity among a panel of transgenic 
hybridomas that expressed an identical B chain (V/~8.1DB2JB2.3CB2). Sequence analysis revealed 
that junctional residues of the TCR oe chain and/or Vo~/Jo~ combinations influenced the MHC 
haplotype fine specificity for Mls-1. Third, D/3J~ influences were implicated, in that the transgenic 
hybridomas expressed distinctive patterns of Mls-1 fine specificity not represented among V~8.1 + 
nontransgenic hybridomas. The findings that T  cell recognition of endogenous superantigen 
is MHC specific, and that this specificity correlates with non-V~ elements of the TCR, support 
the hypothesis that there is a direct interaction between the TCR and either polymorphic residues 
of the MHC class II molecule or haplotype-specific  dominant peptides presented by class II. 
B 
acterial and retroviral superantigens are characterized by 
their ability to stimulate T  ceils based predominantly 
on the expression of specific TCR VB dements (1, 2), al- 
though non-V/3 dements of the receptor have recently been 
shown to have an influence on reactivity (3-6). MHC class 
II molecules are necessary for presentation of superantigens 
to T  cells, but these responses are not classically MHC re- 
stricted, in that individual T cells are able to recognize a single 
superantigen presented in the context of multiple class II mol- 
ecules. However, it has been shown that class II isotypes and 
alleles vary in their effectiveness as presenting molecules. For 
example, studies with murine clones and hybridomas specific 
for  the  mouse mammary  tumor  virus  (Mtv)l-associated 
superantigen, Mls-1, have shown that I-E molecules tend to be 
stronger presenters than I-A molecules and that different MHC 
haplotypes can be ordered into a  hierarchy  where H-2k/ 
H-2  d are  the  strongest,  and  H-2b/H-2q  are  the weakest, 
presenters  of Mls-1 (7-10).  Based on these findings, it has 
been proposed that the class II molecule acts as a generic sup- 
port for superantigen presentation at the cell surface and that 
the hierarchy of presentation reflects the relative binding affinity 
1 Abbreviations used in  this paper: Mtv,  mouse mammary  tumor virus; 
vSAG-9,  Mtv-9-associated superantigen. 
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cules (11, 12). 
In contrast with this model, our recent studies with the 
Mtv-9-associated  superantigen  (vSAG-9) revealed  that  in- 
dividual Vf117  + T cell hybridomas were able to distinguish 
vSAG-9 presented by different MHC molecules,  suggesting 
that under some circumstances, the class II molecule may play 
a more intimate role in the trimolecular interaction between 
superantigen, TCR, and MHC (13). The current studies were 
undertaken to determine why the recognition of vSAG-9 by 
T cell hybridomas should differ from the recognition of other 
retroviral superantigens, such as Mls-1. It is possible that this 
characteristic  is unique to either the Vf117 dement of the 
TCR, or to the vSAG-9 moiety. Alternatively, individual Mls-1 
reactive T cells may exhibit MHC haplotype specificity, but, 
because they are present at a lower frequency,  have not been 
described. To distinguish these possibilities, we have analyzed 
panels of superantigen-reactive hybridomas for MHC haplo- 
type specificity. We show here that the recognition of Mls-1 
by some T cells is also critically dependent on the haplotype 
of the MHC molecule. In addition, we show that this fine 
specificity is controlled by non-Vfl elements of the TCR, thus 
implicating a direct interaction between the TCR and MHC 
during superantigen engagement, as we and others have pre- 
viously suggested (13-18). 
Materials and Methods 
Mice.  The generation and characterization of the TCR Vfl8.1 
transgenic mice has been described  elsewhere (19). For these studies 
we used a line of transgenic animals that had been repeatedly  back- 
crossed with CBA/CaJ  (H-2  k, Mls-1-)  mice. All conventional 
mouse strains, BxH-7, SWR/J, C57BL/10J, B10.BR, CBA/J, 
CBA/Ca, C3H/HeJ, DBA/2, B10.D2, BALB/c,  and D1.LP, were 
purchased from The Jackson Laboratory (Bar Harbor, ME) and 
maintained at the animal facility at St. Jude Children's Research 
Hospital, under specific pathogen-free conditions. 
Cell Lines.  A20/2J (H-2  d) and LBK (H-2") are B cell lines that 
have been described elsewhere (20, 21). 1H10 and 3G9 are transfec- 
tants of A20/2J and LBK, respectively, that have been transfected 
with the Mtv-9 3' LTR and shown to express high levels of  vSAG-9 
(13, 22, 23). 2HCa-2 is a Vfl8.1/Vcdl § hybridoma that has pre- 
viously been shown to respond strongly to Mls-1 in the context 
of all the MHC haplotypes tested here (6). KE8 is a Vfl5.1 + hy- 
bridoma that recognizes  vSAG-9 presented on both A20/2J (H-2  a) 
and LBK (H-2  a) transfectants (13, 22, 23). Both hybridomas were 
used to control for Mls-1 or vSAG-9 expression on spleen cells and 
transfectants, respectively. 
Generation of Hybridomas.  T cell hybridomas were generated 
by fusion of activated CD4 + T cells with the c~-/fl- variant of 
the T cell thymoma BW5147 (24). Briefly,  lymph node cells from 
three to six animals  were depleted  of erythrocytes,  passed over nylon 
wool to isolate T ceils, and then panned twice on flasks coated 
with the 53-6.72 mAb (anti-CD8) (25), resulting in T cell popula- 
tions that were >98% CD4 §  . The cells were then activated with 
immobilized V/3-specific antibodies (MR9-4 [anti-V/35; 26, 27], 
KJ23 [anti-Vfll7; 28], KJ16 [anti-Vfl8.1/Vfl8.2; 29], B20.1 [anti- 
Vot2; 30]) in  the  presence of 5  x  105/ml mitomycin C  (50 
/xg/ml)-inactivated spleen cells. After 3-5 d, activated T cell blasts 
were purified over Ficoll-Hypaque and expanded in the presence 
of II~2 for a further 2 d before fusion. The Vfl8.1 § and Vf18.2  § 
hybridomas described in Fig. 2 arose in a single fusion of KJ16- 
stimulated T cells and were distinguished using the F23.2 anti- 
body, which  specifically recognizes Vf18.2  § TCR  (9). In  this 
study we only analyzed hybridomas that: (a) were isolated from 
plates in which <25% of the wells were positive for hybridoma 
growth; (b) expressed high levels of the relevant V3 and CD4 (de- 
termined by staining with GK1.5) (31); (c) secreted IL-2  in response 
to TCR ligation by immobilized anti-TCR antibodies; and (d) did 
not respond to superantigen-negative control cell lines or spleen 
ceils (i.e., were not alloreactive). The two panels of Vfl5  + hybrid- 
omas derived from BxH-7 and B10.BR mice were an exception 
to this rule since only 10% of the Vfl5 § hybridomas stably ex- 
pressed CD4,  necessitating the analysis of CD4-  hybridomas. 
However, these hybridomas all expressed high levels of TCR and 
secreted Ib2 in response to immobilized MRg-4 (anti-Vfl5 mAb). 
All hybridomas  were analyzed  as soon as possible  after fusion (within 
3 wk) since their reactivity was strongest at this time, and were 
subsequently retested to confirm their patterns of fine specificity. 
The patterns of  reactivity  for each  individual  hybridoma  were always 
consistent with the initial analysis, although the reactivities were 
sometimes weaker. Hybridomas were always  tested against the en- 
tire panel of spleen cells (or transfectants) and controls within a 
single assay. 
11..2 Assays.  105 responding hybridomas were cultured either 
with 10  s B cell transfectants (A20/2J,  LBK,  1H10, 3G9), l& 
LPS/IL-4-treated spleen cells (32, 33), or immobilized Vfl-specific 
antibodies in 250-/zl cultures. After 24 h, supernatants were tested 
for Ib2 as previously  described (32). 1 U of human rib2 (R & D 
Systems, Minneapolis, MN) represents 160 U of IL-2 in our assay. 
Antibody inhibition studies were done in the standard stimulation 
assay except that purified antibodies (4/~g/ml) were added to the 
cultures. 
cDNA Sequencing.  PCR-amplified cytoplasmic RNA was se- 
quenced as previously described (34). Briefly, cDNA was gener- 
ated from RNA by reverse transcription and amplified by PCR 
using 5' primers specific for the Vol2 family and a 3' Cc~ primer. 
This PCR product was then converted to  ssDNA by unequal 
amplification in a second PCR using a 100:1 ratio of two internal 
nested primers and sequenced by the dideoxynucleotide termina- 
tion method according to the sequenase protocol (U.S. Biochem- 
ical Corp., Cleveland, OH). All oligonucleotides  used in this pro- 
cedure have been previously described (6). 
Results 
MHC-specific Recognition of vSAG-9 by Vl~5 + and V~I7 + 
T Cells.  Previous studies had shown that individual Vf117  + 
hybridomas were able to distinguish vSAG-9 moieties presented 
on different MHC molecules (13). To determine whether 
MHC specificity was a general property of T  cells specific 
for vSAG-9,  or  unique  to  V/317  +  T  cells,  we  compared 
vSAG-9 reactivity of Vfl5 + hybridomas from BxH7 (H-2  k, 
Mtv-9-) mice and VB17 + hybridomas from SWR (H-2q, 
Mtv-9-) mice. 96 Vfl5 + and 90 VI317+/CD4 + hybridomas 
that secreted IIr2 in response  to TCR ligation by the rele- 
vant Vfl antibodies were tested for their ability to specifically 
recognize vSAG-9 presented on either A20 (A  d, E  d) or LBK 
(A  k, E  k) cells transfected with the vSAG-9 gene (13, 22, 23). 
Expression of  vSAG-9 on the transfectants was confirmed using 
a hybridoma, KE8, that recognizes vSAG-9 in the context 
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Figure  1.  MHC-specific  recognition ofvSAG-9 by (A) V35 + hybrid- 
omas derived from BxH-7 (H-2  k, Mtv-9-) mice and (B) VB17+/CD4 + 
hybridomas derived from SWR (H-2q,  Mtv-9-) mice. The position of 
each symbol represents the amount of Ib2 secreted (U/ml) by individual 
hybridomas in response to vSAG-9 presented by either A20/2J (H-2  d) or 
LBK (H-2  k) transfectants. The dashed lines represent the detection limits 
of the Ib2 assay (10 U/ml), and symbols located to the left of or below 
these lines represent hybridomas that secreted <10 U/ml of Ib2 in re- 
sponse to the relevant stimulators. Altogether, 96 VB5 + and 90 VB17  +  / 
CD4 + hybridomas  were identified that all secreted IL-2 in response to im- 
mobilized anti-V/J antibody. For simplicity, only the 40 VB5 + and 71 
V~17+/CD4 +  hybridomas that  responded specifically to  vSAG-9 
presented by either H-2  d and/or H-2  k are shown. Each hybridoma was 
assayed two or three times to confirm the specificity  pattern, and the results 
were always consistent with the initial analysis. The data presented are 
from the earliest assay of these hybridomas. 
of both of these MHC haplotypes (13, and data not shown). 
Analysis of the V35 + hybridomas revealed that only 40 of 
96 (42%) responded to vSAG-9. Nonetheless, these hybrid- 
omas were strongly dependent  on the MHC  haplotype of 
the presenting  cell in  their recognition of vSAG-9 (Fig.  1 
A).  Whereas  some hybridomas recognized vSAG-9 in the 
context of both H-2 k and H-2  a, others recognized vSAG-9 
only in the context of one or the other of these haplotypes. 
These differences in fine specificity did not correlate with the 
expression of either V~5.1 or V~5.2 TCR elements (deter- 
mined by MR9-4, anti-VB5.1/V35.2 and MRg-8, anti-VflS.1 
staining;  data  not  shown)  (26,  27).  Thus,  recognition  of 
vSAG-9 by V35 + T  cells is highly dependent on the MHC 
haplotype of the presenting cell. The majority (71/90, 79 %) 
of the V~17 +/CD4 + hybridomas responded to vSAG-9, and 
many of these hybridomas recognized this  superantigen in 
an MHC-specific manner, consistent with previous observa- 
tions  (Fig.  1 B). 
Recognition of  Mls-1 by Some T Cells Is MHC Specifia  Most 
VB8.1 + and some VB8.2 + T  cells have been shown  to be 
Mls-1  reactive (9).  To analyze the role of MHC  molecules 
in  this  interaction,  we  generated  a  panel  of V~8.1 +  and 
V~8.2 + hybridomas from C57B1/10 mice (H-2  b, Mls-1-). 
Altogether,  we  characterized  17  V~8.1+/CD4 +  and  31 
VB8.2 +/CD4 + hybridomas for their reactivity to the Mls-1 
antigen presented on spleen cells expressing three different 
MHC haplotypes, H-2  k, H-2  a, and H-2  b (CBA/J, DBA/2, 
D1.LP). Mls-1 expression on the spleen cells was confirmed 
with a well-characterized hybridoma, 2HCa-2, that is strongly 
reactive to Mls-1  presented in the context of all the MHC 
haplotypes  tested (6).  Mls-1  specificity among  the hybrid- 
omas was confirmed using MHC-matched spleen cells that 
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Figure 2.  lb2 secretion (see legend to Fig. 1) by V~88.1+/CD4  + hy- 
bridomas (A and B) and VBS.2+/CD4 * hybridomas (C and D) in re- 
sponse to Mls-1 presented by H-2  d (DBA/2J) vs. H-2  k (CBA/J) spleen 
cells (A and C) or H-2  a (DBA/2J) vs. H-2  b (DI.LP) spleen cells (B and 
D). Spleen cells were pretreated for 24 h with LPS and Ib4 to increase 
Mls-1 expression. All hybridomas were derived from a single fusion of 
KJ16 (anti-V/~8.1/V~8.2)-activated CD4 + cells from C57BL/10 (H-2  b, 
Mls-1-) mice. Altogether, 17 V~/8.1+/CD4  + and 31 VB8.2+/CD4 + hy- 
bridomas were identified that secreted IL-2 in response to immobilized 
KJ16. For simplicity, only the 17 V~88.1+/CD4 + and 12 VB8.2+/CD4 + 
hybridomas that responded specifically  to Mls-1 presented in the context 
of H-2  k, H-2  d, or H-2  b are shown. Each hybridoma was assayed two or 
three times to confirm the specificity  pattern, and the results were always 
consistent with the initial analysis. The data presented  are from the earliest 
assay of these hybridomas. 
do  not  express Mls-1  (CBA/Ca,  B10.D2,  C3H,  B10.BR, 
BALB/c, C57B1/10). All 17 of the V38.1 § hybridomas rec- 
ognized the Mls-1 superantigen. A comparison of reactivity 
of individual  hybridomas  to  Mls-1  presented by H-2 k vs. 
H-2  d (Fig.  2 A)  and  H-2  b vs.  H-2  d (Fig.  2 B) revealed no 
evidence of MHC-specific recognition of Mls-1, contrasting 
strongly with the MHC-dependent reactivity of the V317 + 
and  V/35 +  hybridomas  to  vSAG-9.  In  general,  each  hy- 
bridoma  responded  more  strongly  to  Mls-1  presented  by 
H-2  ~ and H-2  d than to Mls-1 presented by H-2  b, consistent 
with the findings of others that there is a hierarchy of reac- 
tivity to Mls-1 presented by different MHC alleles. The fact 
that  there is  a linear relationship between different MHC 
haplotypes in terms of their ability to present Mls-1 supports 
the concept that this hierarchy is controlled by the affinity 
of the Mls-1 molecule for different MHC class II alleles and 
not by individual  TCRs  (7-10). 
In contrast to the V38.1 + hybridomas,  V38.2 + hybrid- 
omas varied greatly in their recognition of Mls-1 presented 
by different MHC class II alleles (Fig. 2, C and D). Although 
only 12 of the 31 V38.2 hybridomas (39%) were Mls-1 reac- 
tive,  several (7/12)  of these  hybridomas  recognized Mls-1 
presented exclusively by either H-2  k or H-2  d. Relatively few 
435  Woodland  et al. (3/12) of the V/~8.2 hybridomas recognized Mls-1 presented 
by H-2 b. This MHC fine specificity could not be attributed 
simply to differences in the density of class II/Mls-1 mole- 
cules on the presenting cell since all of the presenting cells 
were strong stimulators of at least some of the hybridomas. 
Nor could the fine specificity of the hybridomas be attrib- 
uted to differences in the density of TCR,  CD4,  or other 
adhesion molecules, since individual hybridomas had distinctive 
specificities inconsistent with variations in nonspecific adhe- 
sion molecules. Similarly, the fine specificity could not be 
attributed to the recognition of other superantigens,  such 
as Mls-2/3 or vSAG-9, since the hybridomas did not respond 
to Mls-1  negative,  MHC-matched  C3H/HeJ  (Mls-2/3+), 
B10.BR (vSAG-9+), or BALB/c (Mls-3 + , vSAG-9 +) spleen 
cells (data not shown). Taken together, these data establish 
that T  cell recognition of the Mls-1  superantigen by some 
T  cells is highly MHC specific.  In addition, the differences 
in Mls-1 recognition by VB8.1 + vs.  vBg.2 §  T  cells illus- 
trates that the VB element of the TCR directly influences 
MHC-specific recognition of superantigen. 
Interestingly, the frequency of vBg.2 + hybridomas that 
responded to Mls-1 in these studies (39%) was significantly 
higher than that reported in other studies (9, 35). This dis- 
crepancy may, in part, be explained by our screening proce- 
dures, which identify hybridomas specific for Mls-1 presented 
on MHC  haplotypes other than H-2L  However,  an addi- 
tional factor is likely to be the LPS and II.-4 treatment of 
spleen cells, which greatly enhances Mls-1 expression (32, 33). 
mnC.specific Recognition of  Mls-1 by Vfl8.1 Hybridomas  from 
a Transgenic  Mouse.  There are two possible explanations for 
the observation that V/38.2 +, but not VB8.1 +, T  cell hy- 
bridomas recognize Mls-1 in an MHC-specific manner. First, 
it is possible that there is a fundamental difference in the rec- 
ognition of Mls-1 by these two receptor elements. Alterna- 
tively, it is possible that there is a difference in the relative 
frequencies of MHC-specific, Mls-l-reactive cells. In the latter 
case, our failure to detect MHC-specific recognition of Mls-1 
by vBg.1 + hybridomas may reflect a low frequency, rather 
than absence, of such cells.  To determine whether at least 
some V~8.1 T cells can distinguish Mls-1 presented on different 
MHC molecules, we generated a panel of T cell hybridomas 
from a transgenic mouse (H-2 ~, Mls-1-)  that expresses an 
identical vBg.1/DB2/J~/2.3/CB2 TCR B chain on essentially 
every T  cell (6,  19).  75  V~/8.1 +  CD4 + hybridomas were 
analyzed for their ability to recognize Mls-1 presented in the 
context of three different MHC haplotypes, as described above. 
60 of these hybridomas (80%) specifically recognized Mls-1. 
However, the pattern of fine specificity among the transgenic 
vBg.1 + hybridomas differed from that of the nontransgenic 
vBg.1 +  hybridomas  and was  distributed  into two  major 
groups. Whereas some of the transgenic hybridomas recog- 
nized Mls-1 presented by all haplotypes tested (k, d, and b), 
~ther hybridomas recognized Mls-1 presented only in the con- 
text of k and b (Fig. 3, A  and B). The distinction between 
these phenotypes is clearest in a comparison of recognition 
of  Mls-1  presented  by  H-2 a  vs.  H-2 h  (Fig.  3  B).  The 
significant lack of H-2 a specificity was especially surprising 
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Figure  3.  Ib2 secretion (see legend to Fig. 1) by transgenic VB8.1 + / 
CD4 § hybridomas (A and B) and transgenic Vj88.1*/Vcr  +/CD4  § hy- 
bridomas (C and/9)  in response to Mls-1 presented by CBA/J (Mls-1 *, 
H-21')  vs.  D1.LP  (Mls-1 + ,  H-2  b)  spleen  cells  (A  and  C)  or  DBA/2J 
(Mls-l+, H-2  d) vs. D1.LP (Mls-1 +, H-2  b) spleen cells (B and D). Spleen 
cells were pretreated for 24 h with LPS and I1:4 to increase Mls-1 expres- 
sion. Open symbols represent those hybridomas that expressed V~2 epi- 
topes. All hybridomas were derived from Vj88.1 transgenic mice in which 
the  transgene  has  been  repeatedly  backcrossed  onto  CBA/CaJ  (H-2L 
Mls-1-) mice. Altogether, 75 V38.1 +/CD4 § hybridomas (derived from 
a single fusion of KJ16-activated T  cells) and 45 vBg.1 +/Vc~2 +/CD4 § 
hybridomas (derived from two separate fusions of B20.1-activated T cells) 
were identified that all secreted Ib2 in response to immobilized KJ16 (anti- 
vBg.1/V~8.2) antibody. For simplicity, only the 60 vBg.1 §  + and 
29  V~8.1+/V~2+/CD4 +  transgenic  hybridomas  that  responded 
specifically  to Mls-1 presented in the context of H-2  k, H-2  d, or H-2  b are 
shown.  Each hybridoma was assayed two or three times to confirm the 
specificity pattern, and the results were always consistent with the initial 
analysis. The data presented are from the earliest assay of these hybridomas. 
since H-2 d is considered a strong presenter of Mls-1 to most 
V~8.1 T cells (9; see also Fig. 2, A  and B). The finding that 
vBg.1 recognition of Mls-1 can also be strongly influenced 
by the MHC haplotype of the presenting cell indicates that 
there is no fundamental difference in recognition of Mls-1 
by vflg.1 +  and V~8.2 §  T  cells.  In addition,  the lack of 
MHC-specific  recognition  among  nontransgenic  vBg.I* 
hybridomas suggests that these cells are represented at only 
a low frequency in normal mice but are amplified in the vflg.1 
transgenic animals due to a skewing of the TCR repertoire. 
Contribution of the TCR cr Chain to MHC-specific Patterns 
of Mts-1 Recognition.  Because all of the hybridomas gener- 
ated from the transgenic mouse express an identical ~ chain, 
any contribution of the TCR to specificity is controlled by 
the ol chain. This is consistent with our findings (6) and others' 
(4, 5) that the TCIL ot chain plays a role in superantigen rec- 
ognition. To further investigate the role of the o~ chain in 
generating the two dominant specificity phenotypes among 
the transgenic hybridomas, we took advantage of a Vow2- 
436  MHC-specific Recognition of Mls-1 by T  Cells specifc antibody. Hybridomas that expressed Vot2 + TCR 
are identified by open  symbols in  Fig.  3, A  and B.  The 
Vow2 ~ hybridomas were very unequally distributed between 
the two phenotypes, in that the majority (7/8) did not recog- 
nize Mls-1 in the context of H-2  a. These data establish that 
the  Vot  element  of the  TCB.  influences  the  MHC  fine 
specificity of Mls-1  recognition. 
To extend the correlation between fine specificity for Mls-1 
and ot chain usage among the Vot2 + hybridomas, a larger 
panel of hybridomas was generated from transgenic T  ceils 
that had been activated with immobilized Vot2-specific mAb. 
Analysis of 29 Vc~2  +/CD4 + hybridomas for their recogni- 
tion of Mls-1 presented on different MHC haplotypes (Fig. 
3,  C  and D) confirmed the finding that Vc~2  + transgenic 
hybridomas had a distinct pattern of Mls-1 specificity. Again, 
the Vot2 + hybridomas were not equally distributed among 
the two phenotypes described for the unselected transgenic 
hybridomas, in that most of the hybridomas did not recog- 
nize Mls-1 presented in the context of H-2  a (Fig. 3 D). Also, 
the Vot2 + hybridomas appeared to be more discriminatory 
in their recognition of Mls-1 presented by either b or k (Fig. 
3 C). Inhibition studies with MHC class II-specific antibodies 
revealed that the two patterns of fine specificity did not corre- 
late with the recognition of I-A vs. I-E, although interest- 
ingly, none of the hybridomas recognized Mls-1 exclusively 
in the context of I-A  k (data not shown). 
The Mls-l-reactive Vot2 + transgenic hybridomas could be 
classified into three distinct groups based on their specificity 
for Mls-1. Groups I and 2 were characterized by their preferen- 
tial recognition of Mls-1  on either H-2  k or H-2  b, but lack 
of response to Mls-1  presented by H-2  d.  The third group 
was distinguished by the (nonexclusive) recognition of Mls-1 
presented by H-2  a.  To determine what component of the 
TCR ot chain controlled the three patterns of MHC specificity 
among the Vot2 hybridomas, we identified the Vc~ family 
member, junctional,  and Jot sequences in each hybridoma. 
As shown in Table 1, usage of particular Vot2 family members 
did not correlate directly with fine specificity for Mls-1. For 
example, the Vot2.3 and Vot2.HCa8 elements were expressed 
frequently among hybridomas with distinctive patterns of 
Mls-1 recognition. Similarly, in general, there was no direct 
correlation between Mls-1 reactivity and Jot usage. However, 
there was a restricted use of Jot elements in group 1 hybrid- 
omas (k>b) in that 8 of 17 of the hybridomas used J~17, 
Jot24, and Jot28 elements. These Jot elements were absent in 
Mls-l-reactive  hybridomas  with  other  patterns  of  fine 
specificity (groups 2 and 3).  Interestingly, two hybridomas 
(4-77 and 4-59) that differed only in junctional residues ex- 
pressed distinctive patterns of fine specificity for Mls-1. This 
is consistent with previous studies that have implicated ot chain 
junctional sequences in Mls-1 reactivity of transgenic hybrid- 
omas (6). Taken together, these data demonstrate that different 
elements of the ot chain contribute to the MHC fine specificity 
of Mls-1 recognition, although we have not identified a simple 
correlation between MHC specificity and usage of particular 
ot chain elements. These observations are consistent with the 
hypothesis that there is a direct interaction between the MHC 
molecule and TCR. during superantigen engagement (11, 
13-18). 
MHC-specific Recognition of Retroviral Superantigens Has Im- 
flications for T Cell Repertoire Selection In Viva  These studies 
demonstrated that in vitro T  cell recognition of retroviral 
superantigens is strongly influenced by the MHC haplotype 
of the presenting cell. However, it was unclear whether such 
fine specificity would have any direct consequences in vivo. 
To investigate this possibility, we made use of the fact that 
endogenous expression of retroviral superantigens mediates 
the clonal elimination or inactivation of T cells bearing poten- 
tially autoreactive TCR (38). We argued that T cells bearing 
TCR. reactive with an endogenous superantigen in the con- 
text of aUogeneic, but not self-, MHC molecules should be un- 
affected by mechanisms of tolerance. To test this, we generated 
a panel of V35 + hybridomas from B10BR (H-2  k, vSAG-9 +) 
mice that, as a consequence of endogenous vSAG-9 expres- 
sion,  express  a low frequency of peripheral V35 §  T  cells 
(26, 32). These hybridomas were then tested for their ability 
to recognize vSAG-9 presented in the context of aIlogeneic 
MHC  (H-2  d,  A20/2J  transfectants)  or  self-MHC  (H-2  k, 
LBK transfectants). Altogether, 31 V35 +, B10.BR hybrid- 
omas were analyzed (Fig.  4 A).  As expected, none of the 
hybridomas recognized vSAG-9 presented in the context of 
self-MHC (H-2k), indicating that T  cells with this specifi- 
city had been tolerized in this animal. However, three of the 
B10.BP,. hybridomas recognized vSAG-9  in the context of 
allogeneic H-2  d,  suggesting that  these vSAG-9-reactive T 
cells had not been deleted in this animal. In contrast, a similar 
panel of hybridomas from MHC-matched, Mtv-9-negative, 
BxH7 mice responded to vSAG-9 presented by either H-2  a 
and/or H-2  k, consistent with the fact that these mice are not 
tolerant to vSAG-9 (Fig.  4 B). These data suggest that fine 
specificity for retroviral superantigens has a direct effect in 
vivo on repertoire selection. Thus, VB5 + T  cells that rec- 
ognized vSAG-9/H-2  k moieties have been functionally toler- 
ized (purged or anergized) in B10.BR mice, leaving a residual 
population ofT cells that either recognize vSAG-9 in the con- 
text of non-self-MHC molecules or are vSAG-9 nonreactive. 
Discussion 
Our previous studies had shown that recognition of the 
Mtv-9-associated superantigen, vSAG-9,  by Vf117 + T  cells 
was strongly influenced by the MHC haplotype of the pre- 
senting cell (13). However, this finding contrasted with the 
large body of work regarding T cell recognition of another 
retroviral superantigen, Mls-1. AI  though different MHC mol- 
ecules clearly varied in their capacity to present Mls-1,  in- 
dividual hybridomas or clones were not reported to distin- 
guish between Mls-1 moieties presented on different MHC 
molecules (7-10).  To better understand the differences be- 
tween T cell recognition of vSAG-9 and Mls-1, we have ana- 
lyzed the specificities  of several panels of hybridomas and 
shown that the Mls-1  superantigen can also be recognized 
in an MHC-specific fashion by some T cells. Thus, these studies 
demonstrate that there is no fundamental difference in the 
437  Woodland et al. Table  1.  Sequence Analysis  of Mls-l-reactive,  Voe2  + Hybridomas Derived from a  V~8.1  Transgenic Mouse 
IL-2 secreted in response to: 
CBA/J  DBA/2  D1.LP 
Hybridoma*  (H-2  k)  (H-2  a)  (H-2  b)  KJ16  Vc~* 
Sequence 
N s  Jo~ 
k>b 
6-7  20 
6-63  20 
6-132  20 
4-77  20 
4-32  40 
4-19  40 
6-2  40 
6-66  40 
4-57  40 
6-186  160 
4-103  320 
6-1  320 
4-34  320 
4-10  320 
6-178  640 
4-104  640 
4-4  1,280 
b>k 
6-122 
4-101 
4-46 
4-75  20 
4-59 
4-24  20 
6-189  40 
4-106  20 
d-reactive 
5-52  >1,280 
6-35  640 
6-68  320 
6-124 
U/ml 
160 
40 
80 
80 
160 
160 
1,280  HCa8  E  34 
2,560  2.5  A  17 
640  2.3  -  2O 
2,560  2.3  GD  39 
2,560  2.3  -  24 
2,560  4HCa-19  EP  16 
80  2.3  N  24 
320  2.3  -  24 
10,240  2.3  E  28 
2,560  2.3  EG  25 
640  HCa8  (A)  17 
1,280  2.3  Y  40 
2,560  HCa8  G  41 
5,120  HCa8  28 
2,560  2.3  -  30 
2,560  2.3  E  28 
2,560  2.3  [NI]  34 
20  640  2.3  V  33 
40  1,280  4HCa-101  SG  34 
40  640  HCa8  R  37 
40  2,560  4HCa-75  D  32 
160  2,560  2.3  F  39 
160  2,560  HCa8  ER  49 
160  2,560  HCa8  KG  40 
640  2,560  HCa8  [NI]  25 
>1,280  >1,280  1,280  HCa8  [NI]  15 
640  320  5,120  4HCa-19  (k)TL  32 
40  -  1,280  HCa8  [NI]  30 
80  -  320  HCa8  A  15 
* The Voe2  + hybridomas presented here are derived from three separate fusions, designated by the prefixes 4,  5,  and 6 in the hybridoma name. 
All hybridomas were generated from VBS.1 transgenic CD4 + cells that were activated with either B20.1 (anti-Voe2, fusions 4 and 6; shown in 
Fig. 3, C and D) or KJ16 (anti-V38.1/V38.2,  fusion 5; shown in Fig. 3, A and B). Hybridoma reactivity is presented as IL-2 secretion in response 
to Mls-1  § spleen cells of the indicated MHC haplotypes or immobilized KJ16 antibody. IL-2 assays and TCR c~ chain sequencing was performed 
as described in Materials and Methods. The groupings k>b, b>k, and d-reactive indicate the relative MHC specificity  of the hybridomas for Mls-1. 
The sequences of V~2.HCaS,  V~2.3,  and Vc~2.5 have been previously published (6, 36, 37). The sequences of 4HCa-19, 4HCa-75, and 4HCa-101 
Vex2 elements will be published separately. 
S Amino acid residues in parentheses were dncoded by the V~ gene. [NI], not identified. 
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Figure 4.  I1:2  secretion by VB5 + hybridomas derived from (.4) B10.BR 
(H-2  k, Mtv-9 +) and (B) BxH-7 (H-2  k, Mtv-9-) mice in response to the 
Mtv-9-associated superantigen,  vSAG-9, presented by either A20/2J (H- 
2  a) or LBK (H-2  k) transfectants,  as described  in Fig.  1.  Altogether,  31 
B10.BR  hybridomas  derived from a single fusion were analyzed in this 
study. The data for the BxH-7 hybridomas  are from Fig. 1 and are shown 
for comparison.  All of the hybridomas  presented here secreted II:2 in re- 
sponse to immobilized MR.9-4 (anti-V35)  antibody  even though many 
of them did not specifically respond to vSAG-9 presented on the transfec- 
tants.  Each hybridoma  was  assayed two or three times to confirm the 
specificity pattern,  and the results were always consistent  with the initial 
analysis. The data presented  are from the earliest of these hybridomas. 
recognition of these two superantigens, but that the frequency 
of MHC-specific, Mls-l-reactive T  cells is low. 
We and others have previously shown influences of non- 
V3 elements of the TCR on endogenous superantigen rec- 
ognition (3-6). The data presented here extend these studies 
to show that these non-VB influences correlate with the MHC 
fine specificity of individual hybridomas. First, a direct role 
for the TCR c~ chain was apparent from the distinct patterns 
of Mls-1 fine specificity among V38.1 + transgenic hybrid- 
omas, which all expressed an identical B chain. Sequence anal- 
ysis of some of these hybridomas did not reveal a direct corre- 
lation between specificity and Vt~ family member usage or 
Jo~ usage,  suggesting that junctional residues or combina- 
tions of these elements control this reactivity. Second, a role 
for non-V3 elements of the 3 chain in Mls-1 fine specificity 
was apparent from the observation that the V38.1 + trans- 
genic  hybridomas  expressed  distinct  patterns  of  MHC 
specificity  that  were  not  found  among  nontransgenic 
V38.1 + hybridomas. It is likely that restriction of the reper- 
toire to a single transgenic 3  chain has amplified a minor 
population of T cells with distinctive specificities in the trans- 
genic animals. 
Although the molecular mechanism underlying MHC- 
specific recognition of retroviral superantigens remains to be 
determined, the involvement of non-V3 elements suggests 
two possibilities. One possibility is that non-V3 elements affect 
the binding of superantigen to the TCR, either directly by 
contacting superantigen or indirectly by inducing a confor- 
mational change in the superantigen binding site on V/~ How- 
ever, this mechanism is unlikely to explain differences in MHC 
specificity as reported here. An alternative possibility, and one 
that we and others have proposed previously, is that MHC- 
specific recognition of superantigen is mediated by a direct 
interaction between the TCR and the MHC class II mole- 
cule during the formation of a superantigen/TCR/MHC 
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complex (11, 13-18). For example, interactions between poly- 
morphic residues of the MHC molecule (and/or bound pep- 
tide) and the c~ chain of the TCR might act to either stabi- 
lize  or  disrupt formation of a  superantigen/TCR/MHC 
complex. In the case of the 3  chain, non-V3 components 
could affect fine specificity either by selecting a repertoire of 
oe chains that confer distinctive Mls-1 specificities on the T 
cell, or by directly contacting the MHC molecule itself. We 
are further investigating these proposed interactions by muta- 
genesis experiments in which mutations in the TCR, MHC 
class II molecules, and Mls-1 will be analyzed for their influence 
on MHC-restricted recognition. 
In the absence of structural information, it is difficult to 
predict how non-VB elements might interact with the MHC 
during superantigen recognition (39, 40). One possibility is 
that the interaction is the same as during recognition of con- 
ventional antigen/MHC.  Alternatively, it is possible  that 
MHC/TCR contact points involved in recognition of su- 
perantigen vs. conventional Ag/MHC might be significantly 
different. For example, the superantigen might rotate the TCR 
out  of its  normal docking orientation,  or  might induce 
significant conformational changes in the TCR or MHC struc- 
ture. Indirect support for the idea that the TCR/MHC in- 
teraction is unconventional comes from our study of Mls-1- 
reactive, VBS.2 + hybridomas. Since these hybridomas were 
derived from a C57B1/10 mouse, the parental T cells should 
have been positively selected by, and presumably have a weak 
affinity for, H-2  b molecules.  If favorable TCR/MHC inter- 
actions are required for the recognition of Mls-1 by Vf18.2 + 
T  cells, then one might have expected to  see significant 
numbers of hybridomas that preferentially recognized Mls-1 
in the context of H-2  b. However, this was not the case, sug- 
gesting that positive selection in the thymus had not directly 
influenced the fine specificity of the T  cells to Mls-1,  and 
supporting the idea that TCR/MHC interactions differ be- 
tween superantigen and classical peptide recognition. An un- 
conventional TCR/MHC interaction during superantigen en- 
gagement might explain  reports suggesting that signaling 
events associated with TCR recognition of superantigen are 
different from those induced by recognition of conventional 
antigen/MHC (41-43). 
An important question raised by these studies is why su- 
perantigen recognition of only some T  cell hybridomas is 
MHC specific. We have previously proposed that this reflects 
differences in affinity between the superantigen and TCR (13). 
Thus, if the affinity between the TCR and the superantigen 
is weak, the stability of the MHC/TCR/superantigen com- 
plex is likely to be strongly influenced by stabilizing or dis- 
ruptive interactions between  the  TCR  and  polymorphic 
residues of MHC (and/or bound peptide), resulting in a high 
frequency of MHC specificity. In contrast, if the TCRAu- 
perantigen interaction is strong, direct TCR/MHC interac- 
tions are likely to have less influence on the stability of the 
trimolecular complex, thus resulting in a lower frequency 
of MHC specificity. In this case, recognition of superantigen 
would reflect the hierarchy that is thought to be controlled 
by variation in the affinity of the superantigen for different 
MHC class II molecules (12). The finding that MHC-specific recognition of Mls-1 was frequent among V~8.2 + and in- 
frequent among VB8.1 + hybridomas is consistent with this 
hypothesis. Although it is not yet possible to directly mea- 
sure the affinities  of individual TCKs for Mls-1, several ob- 
servations indirectly suggest that V~8.1 + T  cells are gener- 
ally of higher  affinity than  V~8.2 + T  cells.  First,  a much 
higher frequency of VB8.1 + hybridomas respond to Mls-1 
(in these experiments, 100% ofV~8.1 hybridomas, compared 
with 39% of V~8.2 + hybridomas, recognized Mls-1  on the 
MHC haplotypes tested). Second, V38.1 + T cells are effec- 
tively  clonally  eliminated  from  the  periphery  of  Mls-1- 
expressing  mice,  whereas  V~8.2 +  T  cells  are  relatively 
unaffected (9). Third, mutational analysis has suggested that 
glycosylation sites  on the V~8.2 element partially obscure 
the Mls-1 binding site.  Removal of these sites by mutation 
restores  Mls-1  recognition  in  some,  but  not  all,  VB8.2 + 
TCRs (35, 44). Additional support for the hypothesis comes 
from the unexpected high frequency of MHC specificity of 
the V38.1 transgenic hybridomas. For reasons that are as yet 
unclear,  this particular  B chain appears to have a relatively 
low affinity for Mls-1. For example, Mls-1 mediates only poor 
clonal deletion of transgenic T cells in these animals (6, 19) 
and in the studies presented here,  only 80%  of transgenic 
T  cells  were Mls-1  reactive.  Thus,  apparent  differences in 
affinity of V38.1, V38.2, and transgenic V38.1 hybridomas 
for  Mls-1  correlate  with  the  different  degrees  of MHC 
specificity in  their  Mls-1 recognition. 
The  finding  that  individual  T  cells  have  different  fine 
specificities  for retroviral  superantigens  has significance  for 
repertoire selection in vivo. We speculated that some T cells 
predicted to be superantigen  reactive on the basis of their 
V~/usage would fail  to be clonally eliminated  during  on- 
togeny because they were unable to recognize the superan- 
tigen  presented  in  the  context  of self-MHC.  Analysis  of 
vSAG-9 reactivity among VB5 + hybridomas from B10.BK 
(Mtv-9 § , H-2  k) mice revealed  that while vSAG-9/H-2  k le- 
activity had been purged (either by deletion or anergy),  it 
was still possible to detect vSAG-9/H-2  a reactivity.  These 
data suggest that  clonal deletion is incomplete,  at least in 
part, because some T cells do not recognize the superantigen 
presented in the context of self-MHC molecules. This hy- 
pothesis is difficult to test directly due to the interference 
of strong alloreactive responses and the possibility that the 
activation of T  cells by Mls-1 on syngeneic and allogeneic 
MHC may induce alternative  activation pathways.  For ex- 
ample, it has been reported that neonatal induction of toler- 
ance to Mls-1 with aUogeneic spleen cells does not result in 
the peripheral deletion of Mls-l-reactive T cells, contrasting 
with the strong clonal deletion of Mls-l-reactive T  cells in- 
duced by syngeneic spleen cells  (45,  46). 
Taken together, the data presented in this paper show that 
T cell recognition of retroviral superantigens, such as vSAG-9 
and Mls-1, can be strongly influenced by the MHC mole- 
cule, resulting in distinct patterns of fine specificity. Moreover, 
the clear involvement of both c~ and 3 chain elements of the 
TCR suggests that there is a direct interaction between the 
TCR and MHC molecule during superantigen engagement. 
These findings have great significance for our understanding 
of T cell reactivity and tolerance to retroviral superantigens. 
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